Showing 409 results

Filters Content type: News, Editors' picks, About HIV Topic: Changing treatment

A change of HIV treatment may be necessary because of side-effects, the development of drug resistance, treatment not being fully effective or because of interactions between HIV drugs and other medications.

Viral load

Persisently detectable viral load at any level increases risk of HIV treatment failure

News
29 August 2013
Kidney problems

Kidney problems linked to tenofovir use, improve with switch to abacavir

News
10 July 2013
Changing treatment

Study supports WHO recommendations for second-line HIV therapy in resource-limited countries

News
4 July 2013
Starting treatment

AZT associated with poorer immunological recovery in people taking first-line HIV treatment in southern Africa

News
22 May 2013
UK health services

London HIV drug prescribing changes – patient satisfaction and clinical outcomes maintained

News
22 April 2013
Resistance

Computer models predict how patients will respond to HIV drugs

Editor's pick
Eurekalert Inf Dis
14 March 2013
People with limited treatment options

New integrase inhibitor dolutegravir helps treatment-experienced people on failing therapy

News
10 March 2013
Changing treatment

Second-line NRTI-sparing regimen proves equally effective for resource-limited settings

News
7 March 2013
New & experimental HIV treatments

Can people with resistant HIV omit NRTIs when switching from a failing regimen?

News
7 March 2013
Starting treatment

Meta-analysis shows superiority of integrase inhibitors in first-line HIV therapy and benefits for people changing treatment due to resistance

News
26 February 2013
HIV treatment

It's tough to make predictions

News
14 February 2013
Treatment outcomes & life expectancy

Australian researchers project that many HIV-positive people will run out of treatment options

News
22 January 2013
Treatment simplification strategies

PI monotherapy for HIV — an idea whose time has passed?

Editor's pick
Journal Watch
5 December 2012
Treatment guidelines

Swiss research identifies factors associated with use of non-recommended HIV therapy

News
5 December 2012
Changing treatment

Raltegravir-resistant HIV stays susceptible to dolutegravir in lab

Editor's pick
International AIDS Society
13 November 2012
Treatment interruptions

Pegylated interferon may maintain HIV suppression and reduce viral DNA integration

Editor's pick
HIVandHepatitis.com
12 November 2012
New & experimental HIV treatments

Is protease inhibitor monotherapy sufficient to keep HIV under control in the brain?

Editor's pick
CATIE
2 November 2012
Generic medicines

The generic generation

News
22 October 2012
People with limited treatment options

Booster HIV Drug Can Be Dropped

Editor's pick
MedPage Today
13 September 2012
Diabetes

Glucose metabolism worsens in HIV treatment-experienced taking NRTI-sparing regimens

News
24 August 2012
Changing treatment

Are antiretroviral switch or simplification studies of benefit for patients?

News
15 August 2012
Finance & funding

First generic HIV drugs could save US at least $920 million a year

News
27 July 2012
Changing treatment

Second-line HIV therapy effective and durable in South Africa, and adherence support could improve rates of viral suppression

News
27 June 2012
Changing treatment

Big delays in switching to second-line ART in South Africa

News
8 June 2012